SWOG S1202 A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer

Objective

This randomized phase III trial studies how well duloxetine hydrochloride works compared to a placebo in treating muscle, bone, and joint pain in patients with early-stage breast cancer receiving hormone therapy.

https://www.clinicaltrials.gov/ct2/show/NCT01598298

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 05/12/2015

Research Study Categories

  • Adult Studies

Specialty

  • Cancer
  • Breast Cancer
Contact
Cancer Clinical Trials at 218-786-3308